AMGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Amgen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
15. November 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amgen Inc. (NASDAQ: AMGN)...
Shifts in the Psoriasis Market Suggest Strong Potential for Emerging Oral Therapies
16. Oktober 2024 14:48 ET
|
Spherix Global Insights
EXTON, PA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biologics have long been the cornerstone of psoriasis (PsO) treatment, valued for their proven efficacy and safety. However, the growing demand for...
Subcutaneous Biologics Market Size & Share to Exceed USD 656.3 Billion by 2034, at CAGR of 12.30% - By PMI
08. Februar 2024 16:30 ET
|
PMI
Covina, Feb. 08, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Subcutaneous Biologics Market size was valued at about USD 205.2 Billion in 2024 and expected to grow at CAGR...
Axial Spondyloarthritis Market Awareness Campaigns Promote Early Diagnosis and Improved Outcomes – By PMI
17. Oktober 2023 13:30 ET
|
PMI
Covina, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Axial Spondyloarthritis affects joints in axial skeleton such as chest, pelvis and spine. Skin and nail changes of Psoriasis, longstanding low back pain,...
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Global Insights
03. Oktober 2023 13:57 ET
|
Spherix Global Insights
Exton, Pennsylvania, Oct. 03, 2023 (GLOBE NEWSWIRE) -- US rheumatologists (n=204) report nearly two-thirds of their psoriatic arthritis (PsA) patients are undergoing treatment with advanced systemic...
Annual Cycling Event in California Raises Over $1 Million to Fight Arthritis, Impacting Nearly 60 Million Adults and Hundreds of Thousands of Children in the U.S.
27. September 2023 12:00 ET
|
The Arthritis Foundation’s California Coast Classic Bicycle Tour
The 23rd California Coast Classic Bike Tour presented by Amgen, kicks off Saturday in San Francisco en route to Los Angeles with two hundred cyclists.
Amgen’s Amjevita Remains the Frontrunner in the US Adalimumab Biosimilars Market, Despite Increased Competition, According to Spherix Global Insights.
14. September 2023 11:37 ET
|
Spherix Global Insights
Exton, Pennsylvania, Sept. 14, 2023 (GLOBE NEWSWIRE) -- This summer ushered in the highly anticipated introduction of a multitude of additional adalimumab biosimilars to the dynamic US immunology...
With Little Remaining Unmet Need for Injectable Biologics for the Treatment of Plaque Psoriasis, US Dermatologists Report the Future is Oral, According to Spherix Global Insights
31. August 2023 16:35 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The biologic treatment armamentarium for plaque psoriasis has arguably experienced some of the most successful developments in recent...
Arthritis Foundation’s National Fundraiser, the California Coast Classic, presented by Amgen, has Contributed $22 Million Towards Research and Programs
23. Mai 2023 17:18 ET
|
The Arthritis Foundation’s California Coast Classic Bicycle Tour
LOS ANGELES, May 23, 2023 (GLOBE NEWSWIRE) -- As America recognizes Arthritis Awareness Month this May, the Arthritis Foundation commemorates 75 years of championing the fight to conquer arthritis,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
08. Mai 2023 21:30 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...